XML 73 R62.htm IDEA: XBRL DOCUMENT v3.25.0.1
Hybrid Instruments Liabilities (Tables)
12 Months Ended
Dec. 31, 2024
Hybrid Instruments [Abstract]  
Schedule of changes in hybrid instrument liability

The following table sets forth the changes in hybrid instruments liability (in millions):

 

Balance at December 31, 2022

 

$

34.2

 

Current period additions

 

 

36.1

 

Current period adjustments

 

 

(2.1

)

Foreign currency effect

 

 

2.3

 

Balance at December 31, 2023

 

 

70.5

 

Current period additions

 

 

 

Current period adjustments

 

 

24.1

 

Current period settlements (a)

 

 

(13.8

)

Foreign currency effect

 

 

(2.7

)

Balance at December 31, 2024

 

$

78.1

 

(a)
On October 1, 2024, the call option for Mestrelab was executed, and Bruker acquired the remaining 19.03% of Mestrelab. As a result of the transaction, Bruker has obtained 100% ownership interest in Mestrelab
Schedule of fair value measurements of hybrid instrument liabilities

The Level 3 fair value measurements of our hybrid instrument liabilities include the following significant unobservable inputs:

Hybrid Instrument Liabilities

Fair Value as of December 31, 2024 (millions)

Valuation Technique

Unobservable Input

Range

Weighted Average (a)

Put / Call Options

78.1

Option Pricing Model

Revenue Risk Premium

1.6% - 12.6%

10.70%

 

 

 

EBITDA Risk Premium

10.1% - 25.1%

21.70%

a)
Unobservable inputs were weighted by the relative fair value of the hybrid instrument liabilities.